Keyphrases
Colorectal Cancer Patients
100%
Systemic Analysis
100%
Systemic Inflammatory Response
100%
CD8-positive T Cells
100%
Curative Surgery
100%
Predictive Biomarker
100%
C-reactive Protein
75%
Tumor-infiltrating Lymphocytes
75%
Microsatellite Instability-high (MSI-H)
75%
C-reactive Protein Level
50%
Colorectal Cancer
50%
Disease-free Survival
50%
Platelet-to-lymphocyte Ratio
50%
Colorectal Tissue
50%
Molecular Status
50%
Response Status
50%
Neutrophil-lymphocyte Ratio
50%
KRAS mutation
25%
Multivariate Analysis
25%
Immunohistochemistry
25%
Serum C-reactive Protein
25%
Prediction Accuracy
25%
CD8+ T Cells
25%
Significant Predictors
25%
Forkhead Box P3 (FOXP3)
25%
Early Recurrence
25%
Patients with Colorectal Cancer
25%
Mononucleotide Repeat
25%
Independent Prognostic Factor
25%
Kaplan-Meier
25%
Microsatellite Markers
25%
BRAF mutation
25%
Early Relapse
25%
Protein Data
25%
Response Indicators
25%
Medicine and Dentistry
Recurrent Disease
100%
Biological Marker
100%
Colorectal Cancer
100%
C Reactive Protein
55%
T Cell
44%
Lymphocyte
44%
CD8 Antigen
44%
Serositis
44%
Microsatellite Instability
33%
Tumor Infiltrating Lymphocyte
33%
Neutrophil
22%
Platelet
22%
Disease Free Survival
22%
Cancer Tissue
22%
Immunohistochemistry
11%
Cytotoxic T-Cell
11%
Multivariate Analysis
11%
Retrospective Study
11%
Predictive Factor
11%
Microsatellite Marker
11%
Immunology and Microbiology
C-Reactive Protein
100%
T Cell
80%
CD8
80%
Lymphocyte
80%
Inflammation Response
80%
Microsatellite Instability
60%
Tumor-Infiltrating Lymphocytes
60%
Neutrophil
40%
Platelet
40%
Disease Free Survival
40%
Cancer Tissue
40%
Cytotoxic T-Cell
20%
Microsatellite Marker
20%
Biochemistry, Genetics and Molecular Biology
C-Reactive Protein
100%
T Cell
100%
CD8
100%
Lymphocyte
80%
Microsatellite Instability
60%
Tumor-Infiltrating Lymphocytes
60%
Platelet
40%
Disease Free Survival
40%
KRAS
20%
Multivariate Analysis
20%
Microsatellite Marker
20%
Retrospective Study
20%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Recurrent Disease
100%
Colorectal Cancer
100%
C Reactive Protein
55%
CD8 Antigen
55%
Inflammation
44%
Neoplasm
33%
Disease Free Survival
22%
Retrospective Study
11%
Microsatellite DNA
11%